Cargando…
The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and can result in complete remissions even at advanced stages of the disease. However, only a small fraction of patients respond to the treatment. To better understand which factors drive clinical benefit, we have generated whol...
Autores principales: | Boll, Lilian Marie, Perera-Bel, Júlia, Rodriguez-Vida, Alejo, Arpí, Oriol, Rovira, Ana, Juanpere, Núria, Vázquez Montes de Oca, Sergio, Hernández-Llodrà, Silvia, Lloreta, Josep, Albà, M. Mar, Bellmunt, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504302/ https://www.ncbi.nlm.nih.gov/pubmed/37714872 http://dx.doi.org/10.1038/s41598-023-42495-2 |
Ejemplares similares
-
Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
por: Bowden, Michaela, et al.
Publicado: (2020) -
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
por: Hernández-Llodrà, Silvia, et al.
Publicado: (2017) -
Urothelial carcinoma management in elderly or unfit patients()
por: Bellmunt, Joaquim, et al.
Publicado: (2016) -
New treatment options for metastatic renal cell carcinoma
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2017) -
Correction: Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse
por: Riera, Marta, et al.
Publicado: (2014)